Literature DB >> 33734943

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2021        PMID: 33734943      PMCID: PMC7993116          DOI: 10.1080/21645515.2021.1894892

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.

Authors:  Laura Kolb; Elif Diken; Christina Krienke; Michael Streuber; Sarah Kirchhoff; Thomas Bukur; Özlem Akilli-Öztürk; Lena M Kranz; Hendrik Berger; Jutta Petschenka; Mustafa Diken; Sebastian Kreiter; Nir Yogev; Ari Waisman; Katalin Karikó; Özlem Türeci; Ugur Sahin
Journal:  Science       Date:  2021-01-08       Impact factor: 47.728

2.  SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.

Authors:  Jinal N Bhiman; Penny L Moore; Constantinos Kurt Wibmer; Frances Ayres; Tandile Hermanus; Mashudu Madzivhandila; Prudence Kgagudi; Brent Oosthuysen; Bronwen E Lambson; Tulio de Oliveira; Marion Vermeulen; Karin van der Berg; Theresa Rossouw; Michael Boswell; Veronica Ueckermann; Susan Meiring; Anne von Gottberg; Cheryl Cohen; Lynn Morris
Journal:  Nat Med       Date:  2021-03-02       Impact factor: 53.440

3.  Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.

Authors:  Sandile Cele; Inbal Gazy; Laurelle Jackson; Shi-Hsia Hwa; Houriiyah Tegally; Gila Lustig; Jennifer Giandhari; Sureshnee Pillay; Eduan Wilkinson; Yeshnee Naidoo; Farina Karim; Yashica Ganga; Khadija Khan; Mallory Bernstein; Alejandro B Balazs; Bernadett I Gosnell; Willem Hanekom; Mahomed-Yunus S Moosa; Richard J Lessells; Tulio de Oliveira; Alex Sigal
Journal:  Nature       Date:  2021-03-29       Impact factor: 49.962

4.  mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.

Authors:  Zijun Wang; Fabian Schmidt; Yiska Weisblum; Frauke Muecksch; Christopher O Barnes; Shlomo Finkin; Dennis Schaefer-Babajew; Melissa Cipolla; Christian Gaebler; Jenna A Lieberman; Thiago Y Oliveira; Zhi Yang; Morgan E Abernathy; Kathryn E Huey-Tubman; Arlene Hurley; Martina Turroja; Kamille A West; Kristie Gordon; Katrina G Millard; Victor Ramos; Justin Da Silva; Jianliang Xu; Robert A Colbert; Roshni Patel; Juan Dizon; Cecille Unson-O'Brien; Irina Shimeliovich; Anna Gazumyan; Marina Caskey; Pamela J Bjorkman; Rafael Casellas; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig
Journal:  Nature       Date:  2021-02-10       Impact factor: 69.504

5.  Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.

Authors:  C Garrett Rappazzo; Longping V Tse; Chengzi I Kaku; Daniel Wrapp; Mrunal Sakharkar; Deli Huang; Laura M Deveau; Thomas J Yockachonis; Andrew S Herbert; Michael B Battles; Cecilia M O'Brien; Michael E Brown; James C Geoghegan; Jonathan Belk; Linghang Peng; Linlin Yang; Yixuan Hou; Trevor D Scobey; Dennis R Burton; David Nemazee; John M Dye; James E Voss; Bronwyn M Gunn; Jason S McLellan; Ralph S Baric; Lisa E Gralinski; Laura M Walker
Journal:  Science       Date:  2021-01-25       Impact factor: 63.714

6.  Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapy.

Authors:  Sophie M Poznanski; Tyrah M Ritchie; Isabella Y Fan; Abdullah El-Sayes; Ana L Portillo; Ronny Ben-Avi; Eduardo A Rojas; Marianne V Chew; Yaron Shargall; Ali A Ashkar
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.